Institutional shares held 15.6 Million
107K calls
0 puts
Total value of holdings $71.9M
$491K calls
$0 puts
Market Cap $244M
52,950,000 Shares Out.
Institutional ownership 29.52%
# of Institutions 46


Latest Institutional Activity in ENOB

Top Purchases

Q2 2025
Millennium Management LLC Shares Held: 2.15M ($9.89M)
Q2 2025
Jane Street Group, LLC Shares Held: 893K ($4.11M)
Q2 2025
Goldman Sachs Group Inc Shares Held: 595K ($2.74M)
Q2 2025
Marshall Wace, LLP Shares Held: 309K ($1.42M)
Q2 2025
Qube Research & Technologies LTD Shares Held: 229K ($1.05M)

Top Sells

Q2 2025
State Street Corp Shares Held: 357K ($1.64M)
Q2 2025
Geode Capital Management, LLC Shares Held: 1.02M ($4.67M)
Q2 2025
Vanguard Group Inc Shares Held: 4.92M ($22.7M)
Q2 2025
Northern Trust Corp Shares Held: 214K ($985K)
Q2 2025
Ubs Group Ag Shares Held: 125K ($573K)

About ENOB

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.


Insider Transactions at ENOB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
500K Shares
From 2 Insiders
Grant, award, or other acquisition 500K shares
Sell / Disposition
1.18M Shares
From 2 Insiders
Other acquisition or disposition 350K shares
Sale (or disposition) back to the issuer 833K shares

Track Institutional and Insider Activities on ENOB

Follow Enochian Biosciences Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENOB shares.

Notify only if

Insider Trading

Get notified when an Enochian Biosciences Inc insider buys or sells ENOB shares.

Notify only if

News

Receive news related to Enochian Biosciences Inc

Track Activities on ENOB